Report
Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.
Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly)
- Report Code : TIPRE00004070
- Pages : 209
The influenza vaccines market is expected to grow from US$ 7,478.53 million in 2021 to US$ 12,272.49 million by 2028. It is expected to grow with a CAGR of 7.4% from 2022 to 2028. Increasing government support to promote influenza vaccination and rising investment by top market players and governments are the major factors boosting the market.
The governments of various states are supporting the promotional activities of vaccination program. For instance, the Australian government gives a free seasonal influenza vaccine to those at risk of influenza-related complications through the National Immunization Program (NIP). By 2022, enough vaccines have been given to cover all risk groups eligible for a government-funded flu vaccine through the NIP.
Below are a few more instances supporting the government support for influenza vaccination:
• In July 2022, Public Services and Procurement Minister Filomena Tassi and Health Minister Jean-Yves Duclos announced that the Government of Canada had signed a new contract with GlaxoSmithKline (GSK) to support a sustainable influenza pandemic readiness. The Government of Canada maintains pandemic influenza vaccine preparedness in the event of an influenza pandemic.
• In July 2022, Health Minister Audrey Gordon and Long-term Care Minister Scott Johnston announced that the Manitoba government would expand the high-dose flu vaccine eligibility to include all adults aged 65 and over to ensure more Manitoba people are protected against influenza.
• The Victorian government received a grant and reimbursement program to help GPs and pharmacies improve access and uptake of the influenza vaccines by June and July 2022.
• In June 2022, The New Zealand government expanded the access to free flu vaccines, with an additional 800,000 New Zealanders eligible from July 1, 2022. Children aged 3 to 12 years and people with severe mental health or addiction problems can now get a free dose of the flu vaccines.
• Taiwan’s Centers for Disease Control (Taiwan CDC), and the Ministry of Health and Welfare, organized a media event, titled “Let’s Stay Healthy Together” to kick off the 2021 government-funded influenza vaccination program. At the event, Director General Chou, Ambassador Tan, and Hsin Chiang were the first to be vaccinated to encourage eligible people to receive government-funded flu vaccines to get their flu vaccinations as soon as possible following the program.
• In September 2019, US President Donald Trump signed an executive order to promote the development of better vaccines to protect against seasonal flu and the potential for pandemic flu outbreaks.
• In Oct 2021, with flu season approaching, the Provincial Government was encouraging all Newfoundlanders and Labradorians to get a flu shot in the year 2021. Starting October 25, 2021, the Regional Health Authorities (RHAs) have begun hosting free flu vaccination clinics. People can also get the vaccine through their family doctor or local pharmacy. Thus, increasing government support to promote influenza vaccination worldwide is driving the influenza vaccines market.
Vaccine Type Insights
Based on the vaccine type, the influenza vaccines market is segmented into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment is likely to hold a larger market share in 2022. The same segment is anticipated to register a higher CAGR during the forecast period. The quadrivalent influenza (flu) vaccine protects against 4 influenza viruses, including 2 influenza A viruses and 2 influenza B viruses. All flu vaccines in the US during the 2021-2022 season are quadrivalent vaccines. Different vaccines are approved for different age groups.
Virus Type Insights
Based on virus type, the influenza vaccines market is segmented into influenza virus type A and influenza virus type B. The influenza virus type A segment is likely to hold a larger market share in 2022. The same segment is expected to record a faster CAGR during the forecast period. The market growth of the influenza virus type A segment is because it is the most common form of influenza and can infect animals, although illnesses associated with this type of flu are more common.
Technology Insights
Based on technology, the influenza vaccines market is segmented into egg-based and cell-based. The egg-based segment is likely to hold a larger market share in 2022. The same segment is expected to record a faster CAGR during the forecast period. The market growth of the egg-based segment is due to its most common method of producing flu vaccines through an egg-based manufacturing process that has been used for more than 70 years.
Route of Administration Insights
Based on route of administration, the influenza vaccines market is segmented into injection and nasal spray. The injection segment is likely to hold a larger market share in 2022. The same segment is expected to register a higher CAGR during the forecast period. The market growth of the injection segment is attributed to the fact that it is the most common method for flu vaccine administration.
Target Group Insights
Based on target group, the global influenza vaccines market is divided into infants, children, adults, and elderly people. The infants segment held larger share of the market in 2021. However, the elderly (geriatric population) segment is expected to grow at the highest growth rate during the forecast period.
International Trade Administration (ITA), Farmindustria-Bain & Company, EFPIA member associations, World Health Organization (WHO), Business Monitor International (BMI), Department of Emergency Medicine, and Indian Journal of Medical Sciences are among the primary and secondary sources referred to while preparing the report on the influenza vaccines market.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Influenza Vaccines Market – By Vaccine Type
1.3.2 Global Influenza Vaccines Market – By Virus Type
1.3.3 Global Influenza Vaccines Market – By Technology
1.3.4 Global Influenza Vaccines Market – By Route of Administration
1.3.5 Global Influenza Vaccines Market – By Target Group
1.3.6 Global Influenza Vaccines Market – By Geography
2. Influenza Vaccines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Influenza Vaccines Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Experts Opinion
5. Global Influenza Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Government Support to Promote Influenza Vaccination
5.1.2 Increasing Investment by Top Market Players and Governments
5.2 Market Restraints
5.2.1 High Cost of Vaccine Development
5.3 Market Opportunities
5.3.1 Emerging Economies
5.4 Future Trends
5.4.1 Strong Pipeline Candidates for Influenza Vaccines
5.5 Impact Analysis
6. Influenza Vaccine Market –Global Analysis
6.1 Global Influenza Vaccines Market Revenue Forecasts And Analysis
6.2 Global Influenza Vaccines Market, By Geography – Forecasts And Analysis
6.3 Global Influenza Vaccines Market – Market Potential Analysis, By Region
6.4 Company Analysis
6.4.1 Market Positioning of Key Players
6.4.2 Comparative Company Analysis
6.5 Growth Strategy Analysis
6.6 Performance of Key Players
6.6.1 Sanofi
6.6.2 SEQIRUS
7. Influenza Vaccines Market Analysis and Forecasts To 2028 – By Vaccine Type
7.1 Overview
7.2 Global Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)
7.3 Quadrivalent Vaccines
7.3.1 Overview
7.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Trivalent Vaccines
7.4.1 Overview
7.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8. Influenza Vaccines Market Analysis and Forecasts To 2028 – By Virus Type
8.1 Overview
8.2 Global Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)
8.3 Influenza Virus Type A
8.3.1 Overview
8.3.2 Influenza Virus Type A Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Influenza Virus Type B
8.4.1 Overview
8.4.2 Influenza Virus Type B Market Revenue and Forecast to 2028 (US$ Mn)
9. Influenza Vaccines Market Analysis and Forecasts To 2028 – By Technology
9.1 Overview
9.2 Global Influenza Vaccines Market, By Technology 2022 & 2028 (%)
9.3 Egg-based
9.3.1 Overview
9.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Cell-based
9.4.1 Overview
9.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10. Influenza Vaccines Market Analysis and Forecasts To 2028 – By Route of Administration
10.1 Overview
10.2 Global Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)
10.3 Injection
10.3.1 Overview
10.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Nasal Spray
10.4.1 Overview
10.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11. Influenza Vaccines Market Analysis and Forecasts To 2028 – By Target Group
11.1 Overview
11.2 Global Influenza Vaccines Market, By Target Group 2022 & 2028 (%)
11.3 Infants
11.3.1 Overview
11.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Children
11.4.1 Overview
11.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Adults
11.5.1 Overview
11.5.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Elderly People
11.6.1 Overview
11.6.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
12. Influenza Vaccines Market Analysis and Forecasts To 2028 – Geographical Analysis
12.1 North America Influenza Vaccines Market Revenue and Forecasts To 2028
12.1.1 Overview
12.1.2 North America: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3 North America: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.1.4 North America: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.1.5 North America: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.1.6 North America: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.7 North America: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.1.8 North America: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
12.1.8.1 US: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.1.1 Overview
12.1.8.1.2 US: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.1.3 US: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.1.8.1.4 US: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.1.8.1.5 US: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.1.8.1.6 US: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.8.1.7 US: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.1.8.2 Canada: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.2.1 Overview
12.1.8.2.2 Canada: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.2.3 Canada: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.1.8.2.4 Canada: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.1.8.2.5 Canada: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.1.8.2.6 Canada: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.8.2.7 Canada: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.1.8.3 Mexico: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.3.1 Overview
12.1.8.3.2 Mexico: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.3.3 Mexico: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.1.8.3.4 Mexico: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.1.8.3.5 Mexico: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.1.8.3.6 Mexico: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.8.3.7 Mexico: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.2 Europe: Influenza Vaccines Market
12.2.1 Overview
12.2.2 Europe: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.3 Europe: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.2.4 Europe: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.2.5 Europe: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.2.6 Europe: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.7 Europe: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.2.8 Europe: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
12.2.8.1 Germany: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.1 Overview
12.2.8.1.2 Germany: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.3 Germany: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.2.8.1.4 Germany: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.2.8.1.5 Germany: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.2.8.1.6 Germany: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.8.1.7 Germany: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.2.8.2 UK: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.1 Overview
12.2.8.2.2 UK: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.3 UK: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.2.8.2.4 UK: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.2.8.2.5 UK: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.2.8.2.6 UK: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.8.2.7 UK: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.2.8.3 France: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.1 Overview
12.2.8.3.2 France: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.3 France: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.2.8.3.4 France: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.2.8.3.5 France: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.2.8.3.6 France: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.8.3.7 France: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.2.8.4 Italy: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.1 Overview
12.2.8.4.2 Italy: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.3 Italy: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.2.8.4.4 Italy: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.2.8.4.5 Italy: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.2.8.4.6 Italy: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.8.4.7 Italy: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.2.8.5 Spain: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.1 Overview
12.2.8.5.2 Spain: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.3 Spain: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.2.8.5.4 Spain: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.2.8.5.5 Spain: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.2.8.5.6 Spain: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.8.5.7 Spain: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.2.8.6 Rest of Europe: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.1 Overview
12.2.8.6.2 Rest of Europe: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.3 Rest of Europe: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.2.8.6.4 Rest of Europe: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.2.8.6.5 Rest of Europe: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.2.8.6.6 Rest of Europe: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.2.8.6.7 Rest of Europe: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.3 Asia Pacific: Influenza Vaccines Market
12.3.1 Overview
12.3.2 Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.3 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.3.4 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.3.5 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.3.6 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.3.7 Asia Pacific: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.3.8 Asia Pacific: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
12.3.8.1 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.1.1 Overview
12.3.8.1.2 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.1.3 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.3.8.1.4 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.3.8.1.5 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.3.8.1.6 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.3.8.1.7 Japan: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.3.8.2 China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.2.1 Overview
12.3.8.2.2 China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.2.3 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.3.8.2.4 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.3.8.2.5 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.3.8.2.6 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.3.8.2.7 China: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.3.8.3 India Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.3.1 Overview
12.3.8.3.2 India: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.3.3 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.3.8.3.4 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.3.8.3.5 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.3.8.3.6 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.3.8.3.7 India: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.3.8.4 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.4.1 Overview
12.3.8.4.2 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.4.3 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.3.8.4.4 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.3.8.4.5 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.3.8.4.6 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.3.8.4.7 South Korea: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.3.8.5 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.5.1 Overview
12.3.8.5.2 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.3.8.5.3 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.3.8.5.4 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.3.8.5.5 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.3.8.5.6 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.3.8.5.7 Australia: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.3.8.6 Rest of Asia Pacific: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.6.1 Overview
12.3.8.6.2 Rest of Asia Pacific: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.6.3 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.3.8.6.4 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.3.8.6.5 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.3.8.6.6 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.3.8.6.7 Rest of Asia Pacific: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.4 Middle East & Africa Influenza Vaccine Market Revenue and Forecasts To 2028
12.4.1 Overview
12.4.2 Middle East & Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
12.4.3 Middle East & Africa: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
12.4.4 Middle East & Africa: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
12.4.5 Middle East & Africa Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
12.4.6 Middle East & Africa Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
12.4.7 Middle East & Africa: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.4.8 Middle East & Africa: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
12.4.8.1 Saudi Arabia: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.1.1 Saudi Arabia: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.1.2 Saudi Arabia: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
12.4.8.1.3 Saudi Arabia: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
12.4.8.1.4 Saudi Arabia Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
12.4.8.1.5 Saudi Arabia Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
12.4.8.1.6 Saudi Arabia: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.4.8.2 UAE: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.2.1 UAE: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.2.2 UAE: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
12.4.8.2.3 UAE: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
12.4.8.2.4 UAE Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
12.4.8.2.5 UAE Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
12.4.8.2.6 UAE: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.4.8.3 South Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.3.1 South Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.3.2 South Africa: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
12.4.8.3.3 South Africa: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
12.4.8.3.4 South Africa Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
12.4.8.3.5 South Africa Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
12.4.8.3.6 South Africa: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.4.8.4 Rest of Middle East & Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.4.1 Rest of Middle East & Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.4.2 Rest of Middle East & Africa: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
12.4.8.4.3 Rest of Middle East & Africa: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
12.4.8.4.4 Rest of Middle East & Africa: Influenza Vaccine Market, by Technology, 2019–2028 (USD Million)
12.4.8.4.5 Rest of Middle East & Africa: Influenza Vaccine Market, by Route of Administration, 2019–2028 (USD Million)
12.4.8.4.6 Rest of Middle East & Africa: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.5 South and Central America Influenza Vaccine Market Revenue and Forecasts To 2028
12.5.1 Overview
12.5.2 South and Central America: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.5.3 South and Central America: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
12.5.4 South and Central America: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
12.5.5 South and Central America: Influenza Vaccine Market, by Technology, 2019–2028 (USD Million)
12.5.6 South and Central America: Influenza Vaccine Market, by Route of Administration, 2019–2028 (USD Million)
12.5.7 South and Central America: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.5.8 South and Central America: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
12.5.8.1 Brazil: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.1.1 Overview
12.5.8.1.2 Brazil: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.1.3 Brazil: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
12.5.8.1.4 Brazil: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
12.5.8.1.5 Brazil: Influenza Vaccine Market, by Technology, 2019–2028 (USD Million)
12.5.8.1.6 Brazil: Influenza Vaccine Market, by Route of Administration, 2019–2028 (USD Million)
12.5.8.1.7 Brazil: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.5.8.2 Argentina: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.2.1 Overview
12.5.8.2.2 Argentina: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.2.3 Argentina: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
12.5.8.2.4 Argentina: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
12.5.8.2.5 Argentina: Influenza Vaccine Market, by Technology, 2019–2028 (USD Million)
12.5.8.2.6 Argentina: Influenza Vaccine Market, by Route of Administration, 2019–2028 (USD Million)
12.5.8.2.7 Argentina: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.5.8.3 Rest of South and Central America: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.3.1 Overview
12.5.8.3.2 Rest of South and Central America: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.3.3 Rest of South and Central America: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)
12.5.8.3.4 Rest of South and Central America: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)
12.5.8.3.5 Rest of South and Central America: Influenza Vaccine Market, by Technology, 2019–2028 (USD Million)
12.5.8.3.6 Rest of South and Central America: Influenza Vaccine Market, by Route of Administration, 2019–2028 (USD Million)
12.5.8.3.7 Rest of South and Central America: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
13. Impact of COVID-19 Pandemic on Global Influenza Vaccines Market
13.1 North America: Impact Assessment of COVID-19 Pandemic
13.2 Europe: Impact Assessment of COVID-19 Pandemic
13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
13.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
13.5 South and Central America: Impact Assessment of COVID-19 Pandemic
14. Influenza Vaccine Market –Industry Landscape
14.1 Overview
14.2 Growth Strategies in the Influenza Vaccine Market, 2021-2028
14.3 Inorganic Growth Strategies
14.3.1 Overview
14.4 Organic Growth Strategies
14.4.1 Overview
15. Company Profiles
15.1 Moderna, Inc.
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 SEQIRUS
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Sanofi
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 GlaxoSmithKline plc.
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Hualan Biological Engineering Inc.
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Emergent BioSolutions Inc.
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Mitsubishi Chemical Group Corporation
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Serum Institute of India Pvt. Ltd
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 MYLAN N.V.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 AstraZeneca
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 5. North America Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 6. US Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 9. US Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 10. US Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 21. Europe Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 23. Europe Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 24. Europe Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 25. Europe Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 26. Germany Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 29. Germany Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)
Table 30. Germany Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 31. UK Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. UK: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 33. UK Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 34. UK Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)
Table 35. UK Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 36. France Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 37. France: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 38. France Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 39. France Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 40. France Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 41. Italy Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 42. Italy: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 43. Italy Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 44. Italy Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 45. Italy Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 46. Spain Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 47. Spain: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 48. Spain Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 49. Spain Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)
Table 50. Spain Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 51. Rest of Europe Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Europe: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Europe Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Europe Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)
Table 55. Rest of Europe Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 56. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million).
Table 57. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 58. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 59. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Segment-5 (US$ Million)
Table 60. Asia Pacific Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 61. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 62. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 63. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 64. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 65. Japan Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 66. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 67. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 68. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 69. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 70. China Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 71. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 72. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 73. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 74. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 75. India Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 76. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 77. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 78. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 79. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 80. South Korea Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 81. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 82. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 83. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 84. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 85. Australia Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 86. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 87. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 88. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 89. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 90. Rest of Asia Pacific Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 91. Middle East & Africa Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 92. Middle East & Africa Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 93. Middle East & Africa Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 94. Middle East & Africa Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 95. Middle East & Africa Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 96. Saudi Arabia Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 97. Saudi Arabia Influenza Vaccine Market, by Virus Type– Revenue and Forecast to 2028 (USD Million)
Table 98. Saudi Arabia Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 99. Saudi Arabia Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 100. Saudi Arabia Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 101. UAE Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 102. UAE Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 103. UAE Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 104. UAE Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 105. UAE Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 106. South Africa Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 107. South Africa Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 108. South Africa Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 109. South Africa Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 110. South Africa Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 111. Rest of Middle East & Africa Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 112. Rest of Middle East & Africa Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 113. Rest of Middle East & Africa Influenza Vaccine Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 114. Rest of Middle East & Africa Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 115. Rest of Middle East & Africa Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 116. South and Central America: Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 117. South and Central America: Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 118. South and Central America: Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 119. South and Central America: Influenza Vaccine Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 120. South and Central America Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 121. Brazil: Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 122. Brazil: Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 123. Brazil: Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 124. Brazil: Influenza Vaccine Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 125. Brazil Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 126. Argentina: Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 127. Argentina: Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 128. Argentina: Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 129. Argentina: Influenza Vaccine Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 130. Argentina Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 131. Rest of South and Central America: Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 132. Rest of South and Central America: Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)
Table 133. Rest of South and Central America: Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 134. Rest of South and Central America: Influenza Vaccine Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 135. Rest of South and Central America Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 136. Recent Inorganic Growth Strategies in the Influenza Vaccine Market
Table 137. Recent Organic Growth Strategies in the Influenza Vaccine Market
Table 138. Glossary of Terms, Influenza Vaccines Market
LIST OF FIGURES
Figure 1. Influenza Vaccines Market Segmentation
Figure 2. Influenza Vaccines Market Segmentation, by Region
Figure 3. Global Influenza Vaccines Market Overview
Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in Influenza Vaccines Market
Figure 5. Asia Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Influenza Vaccines Market, By Geography (USD Million)
Figure 7. Global Influenza Vaccines Market- Leading Country Markets (USD Million)
Figure 8. Global Influenza Vaccines Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Global Influenza Vaccines Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 16. Global Influenza Vaccines Market – By Geography Forecasts and Analysis – 2022- 2028
Figure 17. Global Influenza Vaccines Market – Market Potential Analysis, By Region
Figure 18. Market Positioning of Key Players In Global Influenza Vaccines Market
Figure 19. Global Influenza Vaccines Market – Comparative Company Analysis
Figure 20. Global Influenza Vaccines Market – Growth Strategy Analysis
Figure 21. Global Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)
Figure 22. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. Global Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)
Figure 25. Powder Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Tablets Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. Global Influenza Vaccines Market, by Technology 2022 & 2028 (%)
Figure 28. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. Global Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)
Figure 31. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 33. Global Influenza Vaccines Market, by Target Group 2022 & 2028 (%)
Figure 34. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 35. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 37. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 38. North America: Influenza Vaccines Market, by Key Country – Revenue (2022) (US$ Million)
Figure 39. North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 40. North America: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
Figure 41. US: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Canada: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Mexico: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Europe: Influenza Vaccines Market, by Key Country – Revenue (2022) (US$ Million)
Figure 45. Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 46. Europe: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
Figure 47. Germany: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. UK: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. France: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. Italy: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. Spain: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. Rest of Europe: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. Asia Pacific Influenza Vaccines Market Overview, by Country (2022)
Figure 54. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 55. Asia Pacific: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
Figure 56. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 57. China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 58. India: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 59. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 60. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 61. Rest of Asia Pacific: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 62. Middle East & Africa: Influenza Vaccine Market, by Key Country – Revenue (2022) (US$ Million)
Figure 63. Middle East & Africa Influenza Vaccine Market Revenue and Forecast to 2028 (USD Million)
Figure 64. Middle East & Africa: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
Figure 65. Saudi Arabia: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
Figure 66. UAE: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. South Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
Figure 68. Rest of Middle East & Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
Figure 69. South and Central America: Influenza Vaccine Market, by Key Country – Revenue (2022) (USD Million)
Figure 70. South and Central America Influenza Vaccine Market Revenue and Forecast to 2028 (USD Million)
Figure 71. South and Central America: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
Figure 72. Brazil: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
Figure 73. Argentina: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
Figure 74. Rest of South and Central America: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)
Figure 75. Impact of COVID-19 Pandemic on North America Countries
Figure 76. Impact of COVID-19 Pandemic on European Countries
Figure 77. Impact of COVID-19 Pandemic on Asia Pacific Countries
Figure 78. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 79. Impact of COVID-19 Pandemic in South and Central American Countries
Figure 80. Growth Strategies in the Influenza Vaccine Market, 2021-2028
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the influenza vaccines market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global influenza vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
The List of Companies – Influenza Vaccines Market
1. Moderna, Inc.
2. SEQIRUS
3. Sanofi
4. GlaxoSmithKline plc.
5. Hualan Biological Engineering Inc.
6. Emergent BioSolutions Inc.
7. Mitsubishi Chemical Group Corporation
8. Serum Institute of India Pvt. Ltd
9. MYLAN N.V.
10. AstraZeneca
Increasing Investment by Top Market Players and Governments to Drive Global Influenza Vaccines Market
According to our new research study on “Influenza Vaccines Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Vaccine Type, Virus Type, Technology, Target Group, and Route of Administration,” the market was valued at US$ 7,478.53 million in 2021 and is projected to reach US$ 12,272.49 million by 2028. It is estimated to grow at a CAGR of 7.4% from 2022 to 2028. Increasing government support to promote influenza vaccination and investment by top market players and governments worldwide are driving the market. However, the high cost of vaccine development is hampering the market’s growth.
Influenza virus causes flu which is a contagious respiratory illness that infects nose, throat and lungs. It can mild or severe and sometimes may lead to death. Flu vaccination every year can help in preventing flu. However, this can be deadly, especially in high-risk groups. Aged population, pregnant women and people with one or more chronic disease or with weak immune systems are at high risk. Influenza vaccines/flu shots protect against the four influenza viruses subtypes that are most common. Most of the influenza vaccines are “flu shots” given with a needle, usually in the arm, but nasal spray flu vaccine are also available.
Market players and governments worldwide are increasing their investments in vaccine development and immunization. For instance, In March 2021, Sanofi announced an approximately US$ 925 million investment in a new vaccine manufacturing plant at its pre-existing site in Toronto and Canada. Investments in the new facility will provide additional antigen and filling capacity for Sanofi’s FLUZONE high-dose quadrivalent influenza vaccines, increasing availability in Canada, the US, and Europe in the years to come.
In April 2021, 3 levels of the government─federal, provincial, and municipal─supported Sanofi Pasteur in building an “end-to-end” influenza vaccines factory in Toronto. The partners are expected to invest nearly US$ 1 billion to get the site up and running, slated for 2027. Paris-based Sanofi, for its part, will invest more than US$ 55 million, create 165 new eligible jobs, and maintain another 1,100. The federal government is investing US$ 55 million, while the Ontario government is contributing US$ 55 million, making it a US$ 925 million project. In addition, Sanofi will also invest at least US$ 79 million annually over 8 years to fund research and development in Canada.
In June 2021, The European Investment Bank signed a US$ 30.55 million global vaccine distribution agreement with Univercells, a biotech company, to mass produce the COVID-19 vaccine at a new Belgian site. It helped build other vaccine factories around the world. In April 2022, the Bank provided a US$ 15.27 million loan to Italian biomedical research company IRBM to expand its vaccine production capacity and strengthen research on coronaviruses and other diseases.
Thus, the increase in investment by top market players and governments worldwide is bolstering the influenza vaccines market.
Moderna, Inc.; SEQIRUS; Sanofi; GlaxoSmithKline plc.; Hualan Biological Engineering Inc.; Emergent BioSolutions Inc.; Mitsubishi Chemical Group Corporation; Serum Institute of India Pvt. Ltd; MYLAN NV; and AstraZeneca are the leading companies operating in the influenza vaccines market.
Influenza Vaccines Market, by Region, 2022 (%)
Source: The Insight Partners Analysis
Based on vaccine type, the influenza vaccines market is segmented into quadrivalent vaccines and trivalent vaccines. Based on virus type, the market is segmented into influenza virus type A and influenza virus type B. Based on technology, the market is segmented into egg-based and cell-based. Based on route of administration, the market is segmented into injection and nasal spray. Based on target group, the market can be segmented into infants, children, adults, and elderly. By geography, the global market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Related Reports
- $3,000.00 – $5,000.00
